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In Vivo Induction of Cutaneous Inflammation Results
in the Accumulation of Extracellular Trap-Forming
Neutrophils Expressing RORct and IL-17
Romy R.M.C. Keijsers1,2,3, Anke G.M. Hendriks1,3, Piet E.J. van Erp1,3, Bram van Cranenbroek2,
Peter C.M. van de Kerkhof1,3, Hans J.P.M. Koenen2,3,4 and Irma Joosten2,3,4
Clinical trials successfully using antibodies targeting IL-17 in psoriasis support the importance of IL-17 in the
pathophysiology of this disease. However, there is a debate concerning the source and dynamics of IL-17
production in inflamed skin. Here we characterized IL-17-producing immune cells over time, using two
established in vivo models of human skin inflammation that share many histological features with psoriasis,
i.e., leukotriene B4 application and tape-stripping. Both treatments revealed a clear influx of neutrophils and
T cells. Staining for IL-17 revealed that the majority of IL-17 was expressed by neutrophils and mast cells, in both
models. Neutrophils, but not mast cells, coexpressed the IL-17-associated transcription factor RORgt and were
able to form extracellular traps. While the presence of mast cells remained steady during the skin inflammatory
process, the presence of neutrophils was clearly dynamic in time. Therefore, it is attractive to hypothesize that
IL-17þ /RORgtþ neutrophils contribute to human skin inflammation in vivo and possibly to the pathogenesis of
skin diseases such as psoriasis. Surprisingly, T cells represented a minority of the IL-17-expressing cell population.
These observations challenge the classical opinion that IL-17 is predominantly associated with T cells in skin
inflammation.
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INTRODUCTION
Psoriasis is an autoimmune-like chronic inflammatory skin
disease affecting approximately 2% of the population
worldwide (Nestle et al., 2009). It results from an impaired
epidermal barrier function in combination with a
dysfunctional immune system. Psoriasis has a strong genetic
component with 36 associated loci identified by genome-
wide association scans (GWAS) (Tsoi et al., 2012). It is a
neutrophilic dermatosis characterized by epidermal hyper-
plasia, accumulation of polymorphonuclear cells in the
epidermis (microabscesses of Munro), increased vascularity,
and dermal infiltrates containing T lymphocytes and
neutrophils (Mak et al., 2009; Nestle et al., 2009). The
general opinion is that in the pathogenesis of psoriasis
T-helper-17 (Th17) cells and subsequently their key cytokine
IL-17 are important mediators (Mak et al., 2009). Evidence to
further support a crucial role of this pathway in the
pathogenesis of psoriasis results from recently conducted
clinical trials. Treatment with antibodies targeting IL-17 A is
highly effective in psoriasis and causes a rapid improvement of
the disease (Hueber et al., 2010; Leonardi et al., 2012; Papp
et al., 2012). Although initially Th17 cells were considered the
main source of IL-17; recently this paradigm shifted, as
summarized by Krueger (2012). It appears that not only
CD4þ , CD8þ , and gd T cells but also mast cells and
neutrophils are potential sources of IL-17 in psoriasis. Mast
cells and neutrophils release IL-17 through the formation of
extracellular traps (Lin et al., 2011). Moreover, gd T cells and
innate immune cells may contribute substantially more to
the development of psoriasis than conventional Th17 cells
(Cai et al., 2011; Pantelyushin et al., 2012). Of interest, not
only in psoriasis but also for other autoimmune and
inflammatory pathologies it appeared that IL-17 is mainly
associated with mast cells and neutrophils, and not so much
with T cells (Appel et al., 2011; Suurmond et al., 2011;
Noordenbos et al., 2012).
At present, conclusive evidence on which cells in psoriasis
are in fact the main producers of IL-17 and at which time point
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in the inflammatory process they enter the stage is lacking.
In vivo studies on clinically involved psoriatic skin provide us
with static information of the disease at a time point where
symptoms are already present. Ex vivo and in vitro studies
provide a more dynamic picture, but lack the complex
environment, and often make use of lengthy in vitro culture
methods not always resembling the natural situation. To date,
only limited data on the dynamics preceding and during early
clinical disease are available. In the present study, we made
use of two established human models for the induction of skin
inflammation in vivo that both result in different histological
changes that are associated with psoriasis (de Jong et al., 1992;
Gerritsen et al., 1994): the application of leukotriene B4
(LTB4) and tape-stripping.
Leukotrienes are lipid mediators generated in a variety of
inflammatory and allergic conditions affecting the skin, joints,
gastrointestinal system, and respiratory system (Lewis et al.,
1990). High levels of LTB4 were found in lesional skin of
psoriasis (Ziboh et al., 1984; Ruzicka et al., 1986). LTB4 is
produced by the metabolism of arachidonic acid through
the 5-lipoxygenase pathway (Funk, 2001) and is rapidly
generated from activated innate immune cells (Yokomizo
et al., 2001; Murphy and Gijon, 2007). Ligation of
BLT1 (LTB4 receptor-1) by LTB4 causes activation and
recruitment of inflammatory cells. LTB4 is a potent
chemoattractant for neutrophils, eosinophils, monocytes,
macrophages, mast cells, dendritic cells, and effector T cells
(Yokomizo et al., 2001; Friedrich et al., 2003). In vitro LTB4
stimulates epidermal growth (de Jong et al., 1992). Topical
application of LTB4 causes epidermal proliferation, influx of
polymorphonuclear cells in the epidermis (where they
accumulate and form small abscesses), and dermis, followed
by a mononuclear cell infiltrate. Clinically, the application
of LTB4 causes mild erythema and edema at the site of
application.
Tape-stripping results in the removal of the stratum cor-
neum, leading to an impaired epidermal barrier function, such
as that found in psoriasis. Tape-stripping has been extensively
used as an in vivo model to study epidermal proliferation,
keratinization (de Mare et al., 1990; Gerritsen et al., 1994),
and accumulation of polymorphonuclear cells (Chang et al.,
1988).
These two established human models for synchronized
skin inflammation in vivo affect the skin in different
ways, resulting in different histological changes, although
both are associated with the histopathology of psoriasis (de
Jong et al., 1992; Gerritsen et al., 1994). In both models, the
innate and adaptive inflammatory immune response is
induced. This provides a unique platform to study immune
cell dynamics and characteristics in vivo in humans. The
successful anti-IL-17 treatments in psoriasis emphasized the
role of this cytokine in the pathogenesis of psoriasis. We here
assessed innate and adaptive immune cell influx associated
with the initiation and maintenance of the inflam-
matory reaction, i.e., before and during an early clinical
manifestation of human skin inflammation, and evaluated
which cells at which time point were associated with the
production of IL-17.
RESULTS
Topical application of LTB4 leads to subsequent influx of innate
immune cells followed by adaptive immune cells; IL-17þ cells
reside mainly within the innate cell population
Skin of healthy volunteers was challenged with LTB4. Subse-
quently, biopsies were taken at t¼ 0 and after 8, 24, 32, 48,
and 72 hours. Over time, LTB4 caused a gradual increase of
epidermal thickness, influx of immune cells, and small
abscesses in the subcorneal zone of the epidermis (Figure 1a
and b).
The tissues were then characterized for the presence of
CD3, CD4, CD8, Foxp3, IL-17, RORg, elastase, and tryptase
using immunohistochemistry. The number of positive cells for
each marker in the dermis following time after LTB4 applica-
tion was calculated (Figure 1c and Supplementary Table S1
online). As early as 8 hours after the application of LTB4, the
number of immune cells present in the dermis increased. Most
of these cells proved to be elastaseþ neutrophils. Elastase is a
convenient and sensitive marker for the quantification of
neutrophils in the skin (Lammers et al., 1986). However,
elastase is also expressed by macrophages (Horwitz et al.,
1999). Therefore, we additionally stained for myeloperoxidase
(MPO), a naturally occurring constituent of neutrophils, often
used to detect neutrophils in the skin (Bradley et al., 1982; Lin
et al., 2011). The MPO staining pattern matched completely
with the elastase staining, thereby supporting that the
elastaseþ cells that we described are neutrophils (Supple-
mentary Figure S1 online).
The influx of elastaseþ cells in the dermis exponentially
increased with a peak incidence at 24–32 hours, declining
thereafter. Elastaseþ cells even entered the epidermis, causing
microabscesses in the subcorneal zone after 24 hours.
RORgþ and IL-17þ cells showed a similar trend as com-
pared with the elastaseþ cells, with a maximum accumula-
tion at 24–32 hours. Thereafter, their presence declined.
While RORgþ cells were no longer present in the tissue at
72 hours, the number of IL-17þ cells returned to normal
levels, i.e., the same level as that before the application of
LTB4. The presence of dermal tryptaseþ cells, indicative for
mast cells, was stable and did not change upon the applica-
tion of LTB4.
At 48 hours, we observed an influx of T cells, both T-helper
and cytotoxic T cells, in the dermis, marked by the presence of
CD3þ , CD4þ , and CD8þ cells. This influx coincided with
the influx of Foxp3þ cells. All Foxp3þ cells coexpressed
CD25 (Supplementary Figure S2 online), suggesting that these
regulatory T cells (Tregs) are indeed functional Tregs (Chen
and Oppenheim, 2011). T-cell numbers in the epidermis
were low.
The influx of immune cells upon LTB4 application appeared
biphasic, with first an influx of neutrophils at 24 hours,
followed by T cells at 48 hours. As RORgt and IL-17 are
considered the key transcription factor and cytokine of Th17
cells, respectively (Korn et al., 2009), we were surprised to
find the expression of these markers coinciding with granulo-
cyte influx, rather than with the influx of the adaptive immune
cells. This prompted us to further characterize the IL-17þ
and RORgþ cells, using dual-color immunofluorescence.
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Notably, we observed that of all the cell types tested for, only
a subpopulation of elastaseþ neutrophils expressed RORg
(Figure 2a). The majority of these RORgþ cells coexpressed
IL-17 (Figure 2b). Expression of RORg was not found in the
absence of elastase (Figure 2a). Interestingly, although we
found that all tryptaseþ mast cells expressed IL-17
(Figure 2c), they appeared negative for RORg (Figure 2d).
T cells lacked both the expression of RORg and IL-17 at all
time points (Figure 2e and f).
IL-17 expression by dermal immune cells was verified by
carrying out flow cytometry on cell suspensions derived from
skin biopsies. Preliminary results are shown in the Results
section of the Supplementary Data online.
Neutrophils in the epidermis formed specialized structures
called neutrophil extracellular traps (Figure 3) (Brinkmann
et al., 2004), whereas the formation of these structures was not
observed in mast cells.
Now that we established the presence of IL-17 protein in
neutrophils, we wondered whether these cells can make IL-17
themselves. Therefore, we analyzed the presence of IL-17
mRNA in neutrophils by 2-Plex QuantiGene ViewRNA ISH
Tissue Assay (Affymetrix, Santa Clara, CA) on paraffin-
embedded sections of the skin, upon the application of
LTB4 (Figure 4). We observed that in the inflamed skin, IL-
17 mRNA was present in microabscesses, localized in the
subcorneal zone of the epidermis. IL-17 mRNA colocalized
with MPO mRNA. As already shown by immunohistochem-
ical stainings, the abscesses typically consist of accumulated
neutrophils. The housekeeping gene RPLP0 was expressed in
LTB4-challenged skin, as well as in normal skin. Other than in
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Figure 1. Application of LTB4 causes thickening of the epidermis, influx of immune cells, and small abscesses. (a) Hematoxylin and eosin (H&E) stainings of the
skin 0, 8, 24, 32, 48, and 72 hours after the application of leukotriene B4 (LTB4). LTB4 causes a gradual increase of epidermal thickness (indicated by arrow), influx
of immune cells (indicated by #), and small abscesses in the subcorneal zone of the epidermis (indicated by *). Bar¼200mm. (b) Mean thickening of the epidermis
in mm at all time points after application of LTB4 (n¼10). (c) Means±SEM number, as analyzed by immunohistochemistry of CD3þ , CD4þ , CD8þ , Foxp3þ ,
IL-17þ , RORgþ , elastaseþ , and tryptaseþ cells mm2, present in the dermis at six consecutive time points after the application of LTB4 (n¼ 10). *Po0.01 to
the previous measurement in time.
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Figure 2. Dual-color immunofluorescent stainings of inflamed skin after the application of LTB4 and after tape-stripping. Immunofluorescence of (a) RORg (red)
and elastase (green), (b) IL-17 (red) and RORg (green), (c) IL-17 (red) and tryptase (green), (d) RORg (red) and tryptase (green), (e) CD3 (red) and IL-17 (green), and
(f) CD3 (red) and RORg (green). 4’,6-Diamidino-2-phenylindole (DAPI) was used as a counterstain. Arrowheads point toward double positively stained cells.
Bar¼100mm.
OverlayIL-17Elastase OverlayIL-17Elastase
Figure 3. Extracellular trap formation of neutrophils after the application of LTB4. Confocal laser scanning microscopy of (a) neutrophils showing neutrophil
extracellular traps formed of nuclear material and (b) neutrophils with intact nuclei. Both images show neutrophils that display both elastase (green) and IL-17 (red).
Bar¼10mm.
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these subcorneal abscesses, we saw only little presence of
IL-17 mRNA in dermal neutrophils. This may be due to the
detection level of the essay; whereas IL-17 produced by
accumulated neutrophils with consequently higher levels
can easily be detected, IL-17 levels produced by solitary
neutrophils may be missed.
Tape-stripping leads to a simultaneous influx of innate and
adaptive immune cells; IL-17þ cells again mainly reside within
the innate cell population
Having established that after LTB4 application the immune
cell influx is biphasic and that the main source of IL-17 are
neutrophils and mast cells, we next challenged the skin with
tape-stripping, to investigate whether we could confirm our
findings in a different setting.
Biopsies were taken at t¼ 0 and after 16, 24, 48, and
72 hours upon tape-stripping and were processed for immuno-
histochemistry, as described for the LTB4 model. As expected,
removal of the stratum corneum resulted in a gradual
thickening of the epidermis with hyperkeratosis, parakeratosis,
and influx of immune cells (Figure 5a and b).
The numbers of CD3-, CD4-, CD8-, Foxp3-, IL-17-, RORg-,
elastase-, and tryptase-positive cells in the dermis following
time after tape-stripping were calculated (Figure 5c and
Supplementary Table S2 online). At the first measurement,
16 hours after tape-stripping, the accumulation of elastaseþ
cells in the dermis already reached its maximum. Elastaseþ
cells only sporadically infiltrated the epidermis. Seventy-two
hours after tape-stripping, the presence of elastaseþ cells was
drastically diminished and almost comparable to t¼0. Again,
the same pattern was seen for IL-17þ and RORgþ cells in
the dermis. Similar to what we noticed after the application of
LTB4, RORgþ cells disappeared from the tissue, whereas IL-
17þ cells stayed present at the same level as that before tape-
stripping. The number of tryptaseþ mast cells did not change
over time.
We observed a peak incidence of neutrophils (elastaseþ
cells) 16 hours after tape-stripping and the influx of CD3þ ,
CD4þ , CD8þ , and Foxp3þ T cells in the dermis reached a
maximum at 16 hours. The numbers of these T-cell subsets
remained at this high level up to the last measurement at
72 hours. T cells rarely penetrated the epidermis.
In contrast to the LTB4 model, where a biphasic response
was observed, tape-stripping led to a simultaneous influx of
innate and adaptive immune cells. The number of neutrophils
present in the tissue peaked at 16 hours and almost dropped to
undetectable levels at 72 hours. T-cell numbers remained
stable from 16 up to 72 hours after challenging the skin.
The immunohistochemical expression pattern of RORg and
IL-17 by different immune cell subsets after challenging the
skin with tape-stripping was similar to that found in the LTB4
skin model. This may suggest that this pattern is, at least in
part, independent of the mechanism causing the skin trauma.
DISCUSSION
The general consensus at this moment is that IL-17 is a major
driver in the psoriatic process. This notion is strongly
supported by successful treatments with anti-IL-17 antibodies
in patients with psoriasis (Hueber et al., 2010; Leonardi et al.,
2012; Papp et al., 2012). However, the debate on the cellular
source(s) of IL-17 continues. The goal of the present study was
Protein stainings
mRNA stainings
LTB4 skin: merged
LTB4 skin: merged
Normal skin: merged
LTB4 skin: merged
Elastase IL-17
IL-17/RPLP0
IL-17/MPO
IL-17/RPLP0
Anti-rat probe/anti-rat probe
Figure 4. Accumulated neutrophils in the subcorneal zone of the LTB4-
challenged skin contain IL-17 mRNA. (a) Immunohistochemical stainings of
microabscesses in the subcorneal zone of the epidermis, caused by the
application of LTB4. The microabscesses stain positively for elastase and IL-17
(arrows). Bar¼ 100mm. (b) Representative immunofluorescent mRNA stainings
(from n¼4 experiments) for IL-17 (red), RPLP0 (housekeeping gene) (green),
and myeloperoxidase (MPO) (green) on LTB4-challenged skin and normal skin.
As a negative control, anti-rat probes were used instead of anti-human probes.
DAPI was used as a nuclear stain. Microabscesses are marked by the white
dotted line.
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to track the different innate and adaptive immune cells that
have been associated with IL-17 in time, before and during an
early human skin inflammation, and establish which of these
cells in fact produce IL-17 under these circumstances. To this
end, we used two human in vivo models for skin inflammation
that share mechanistic and histological features with psoriasis.
The application of LTB4, a potent PMN chemoattractant, led
to an initial influx of neutrophils, with a peak incidence at
t¼24–32 hours, followed by an influx of T cells at t¼ 48 hours.
A disrupted epidermal barrier function, as induced by tape-
stripping, led to a simultaneous influx of neutrophils and
T cells already at 16 hours. Immunohistochemical characteri-
zation of IL-17-associated cells led to the finding that
neutrophils in both models for skin inflammation have the
ability to express IL-17 from t¼16 hours onward. Further-
more, neutrophils have the machinery to produce IL-17,
marked by the presence of transcription factor RORgt in IL-
17-containing neutrophils. IL-17 mRNA transcripts were
detected in accumulated neutrophils that were present in the
epidermis of our LTB4 skin model, implicating that neutrophils
can make IL-17 themselves. Moreover, we found that
neutrophils were able to release IL-17 via the formation of
extracellular traps. Although the presence of neutrophils was
clearly dynamic, the presence of mast cells remained stable
during the skin inflammatory process induced by LTB4 and
tape-stripping. Mast cells appear to constitutively express IL-17
in the skin, as was also confirmed by Lin et al (Lin et al.,
2011). To our knowledge, it is previously unreported that
these mast cells lack the expression of the IL-17-related
transcription factor RORgt. Extracellular trap formation by
mast cells was not observed in this study. T cells represented
only a minority of the IL-17-expressing cells in these models
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Figure 5. Tape-stripping results in the thickening of the epidermis with hyperkeratosis, parakeratosis, and influx of immune cells. (a) Hematoxylin and eosin
stainings of the skin 0, 16, 24, 48, and 72 hours after tape-stripping. Tape-stripping leads to (partial) removal of the stratum corneum at t¼ 16 hours. This results in a
gradual thickening of the epidermis (indicated by an arrow) with hyperkeratosis, parakeratosis (indicated by *), and influx of immune cells (indicated by #).
Bar¼200mm. (b) Mean thickening of the epidermis in mm at all time points after tape-stripping (n¼ 10). (c) Means±SEM number, as analyzed by immuno-
histochemistry, of CD3þ , CD4þ , CD8þ , Foxp3þ , IL-17þ , RORgþ , elastaseþ , and tryptaseþ cells mm2, present in the dermis at five consecutive time
points after tape-stripping (n¼10). *Po0.01 to the previous measurement in time.
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and lacked the expression of transcription factor RORgt.
Similarly, Lin et al. (2011), conducted a study in psoriatic
patients where they demonstrated that neutrophils and mast
cells, but not T cells, were the predominant cell types
containing IL-17 in the human skin. These predominant cell
types release IL-17 via the formation of extracellular traps. In
this study, no significant increase was observed in the
presence of IL-17þ T cells in the skin of psoriatic patients
versus healthy individuals. Altogether, these observations
challenge the classical opinion that IL-17 is predominantly
associated with T cells.
Upon the application of LTB4, neutrophils in the epidermis
were able to form specialized structures to release IL-17,
termed extracellular traps. They are composed of granule and
nuclear constituents (Brinkmann et al., 2004) and result from a
specialized process of cell death, called ETosis (Wartha and
Henriques-Normark, 2008). The formation of extracellular
traps by neutrophils is, aside from degranulation and phago-
cytosis, a manner to disarm and kill bacteria extracellularly
(Brinkmann et al., 2004). ET formation by neutrophils was
only observed after the application of LTB4 and not after tape-
stripping. This might suggest that LTB4-driven processes, and
not skin barrier disruption, are important in neutrophil
extracellular traps formation in the skin. In these models, we
did not observe extracellular trap formation by mast cells
(MCETs) (von Kockritz-Blickwede et al., 2008).
As expected, the influx of Tregs in the tissue occurred
simultaneously to the influx of proinflammatory CD4þ and
CD8þ T cells, confirming that during skin inflammation both
the proinflammatory and the anti-inflammatory component of
the immune system are simultaneously activated (Dudda
et al., 2008; Tomura et al., 2010). Although IL-17-producing
Tregs were previously identified in severe psoriasis
(Bovenschen et al., 2011), these dysfunctional Tregs could
not be detected in the present setting, suggesting that disease
severity and duration might have a role in the actual
involvement of certain cell types.
In conclusion, psoriasis is usually studied in the context of
present disease. These studies provide us with static informa-
tion of the disease at a time point where symptoms are already
present. As limited data are available involving the dynamics
of immune cells preceding and during early clinical disease,
we used two established models for skin inflammation that
share similarities with psoriasis. By targeting the skin in two
distinct ways, we were able to confirm that our findings were
reproducible and largely independent of the skin model that
was used. Although the dynamics of the innate and adaptive
immune response varied, the cellular sources of IL-17 proved
to be identical in both models. However, it should be noted
that IL-17-expressing cells do not necessarily release the
cytokine. Consequently, it needs to be established whether
IL-17A levels in the cell match the IL-17A levels present in the
microenvironment. A further limitation of our study concerns
the healthy volunteers participating in the study. They prob-
ably lacked genetic susceptibility to the skin disease because
they were free of any signs or history of skin disease.
Most importantly, we found that not T cells but neutrophils
expressing IL-17 in the presence of transcription factor RORgt,
and mast cells, were the main source of IL-17. Although the
presence of mast cells remained steady during the skin
inflammatory process, the presence of neutrophils was clearly
dynamic, suggesting a more important role for neutrophils in
these skin models. Moreover, neutrophils were able to form
specialized structures to release IL-17. On the basis of
increasing evidence from literature, and the present findings
using dynamic skin models, we might have to adjust the
current paradigm on cellular sources of IL-17 in the skin in the
near future. Extrapolation of these results may also have
implications for the pathogenesis of psoriasis.
MATERIALS AND METHODS
Healthy volunteers
After approval by the local medical ethics committee, 20 healthy
adults, 6 men and 14 women, with a mean age of 27 years (range
18–56 years), were recruited according to the Declaration of Helsinki.
All subjects gave their written informed consent. No one suffered
from an inflammatory skin disease or had a history of skin disease.
Furthermore, immunocompromised volunteers or volunteers with an
activated immune system, e.g., during the flu or after a recent
vaccination, were excluded from participation.
In vivo models and tissue handling
Volunteers were assigned to either the application of LTB4 (n¼ 10) or
tape-stripping (n¼ 10). In case of LTB4 application, aliquots of 100 ng
of LTB4 dissolved in 10ml of ethanol were applied in an 8-mm
cylinder on the lower back skin. The ethanol was evaporated under
a stream of nitrogen gas, leaving the LTB4 on the skin. The LTB4
application sites were covered with patch test chambers for 8 hours to
prevent the LTB4 from being displaced. The LTB4 solution was
applied on five sites. Previous experiments showed that application of
pure ethanol in the absence of LTB4, as a control, did not lead to
histological changes, and that the skin was comparable to normal skin
(Camp et al., 1984). Therefore, a biopsy of normal skin served as an
internal control. Subsequently, 3-mm punch biopsies were taken after
8, 24, 32, 48, and 72 hours, respectively.
In the tape-stripping group, adhesive tape (Sellotape) was applied on
metal guard with an opening of 1 2 cm2. The tape was repeatedly
applied and removed (20–80 times) until the stratum corneum was
removed, indicated by glistening skin. Tape-stripping was performed
on two areas on the lower back. Again, a biopsy of intact unstripped
skin functioned as an internal control. After 16, 24, 48, and 72 hours,
3-mm punch biopsies were taken from the tape-stripped skin.
All time intervals were based on the literature search in combina-
tion with in vivo imaging using reflectance confocal microscopy
(Rajadhyaksha et al., 1995, 1999) . On the basis of morphology, we
were able to validate various time points where influx of lymphocytes
and polymorphonuclear leukocytes were expected.
Histochemistry
Immunohistochemical stainings were conducted using anti-human
primary antibodies in the following dilutions: CD3 1:500 (F7.2.38;
Abcam, Cambridge, UK), CD4 1:100 (BC/1F6; Santa Cruz Biotech-
nology, Santa Cruz, CA), CD8 1:100 (C8/144B; Dako, Glostrup,
Denmark), Foxp3 1:100 (PCH101; eBioscience, San Diego, CA),
IL-17 polyclonal goat IgG 1:500 (R&D Systems, Minneapolis, MN),
RORg polyclonal rabbit 1:1000 (Novus Biologicals, Littleton, CO),
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elastase 1:10,000 (NP57; Dako, Glostrup, Denmark), and tryptase
1:100,000 (AA1; Dako). Detailed information on staining procedures
can be found in the Materials and Methods section of the Supple-
mentary Data online.
Quantification of cells and epidermal thickness
The tissues were visualized and photographed by means of a
microscope (Axioskop2 MOT; Zeiss, Oberkochen, Germany) and
digital camera (Axiocam MRc5; Zeiss). Two sequential photographs
of each section were taken at a magnification of 10 , thereby
screening the entire epidermis and dermis. ImageJ (National Institutes
of Health, Bethesda, MD) was used as a tool to automatically count
positively stained cells, as previously described (Keijsers et al., 2013).
This resulted in the number of positive cells mm 2.
Epidermal thickness was measured as follows: for each sample, the
most thickest and the most thinnest parts of the epidermis were
measured (using ImageJ) and mediated.
Statistical analysis
For each time point after the application of LTB4 and tape-stripping,
the results were expressed as means±SEM. The Friedman test was
performed to test for differences between all time points. If the
Friedman test showed a statistically significant result (Po0.05), post
hoc analysis with Wilcoxon signed-rank test was conducted by
comparing each time point with t¼ 0. A Bonferroni correction
was applied, resulting in a significance level set at Po0.01. Analyses
were conducted using SPSS 20.0 (Statitical Package for Social
Sciences, IBM, Armonk, NY).
Transcriptional analysis
mRNA was detected in paraffin-embedded tissue sections of 4-mm
thickness with the QuantiGene ViewRNA ISH Tissue Assay (2-plex),
using the manual as provided by the manufacturer (Affymetrix, Santa
Clara, CA). The following probes were used: type 1 anti-human IL-17
probe, type 6 anti-human MPO probe and type 6 anti-human RPLP0
probe. In short, after deparaffinization, tissue pretreatment was per-
formed by heating the slides for 5 minutes in pretreatment solution
at 95 1C. Thereafter, the tissues were incubated for 10 minutes with
protease solution at 40 1C. The target probes (diluted 1:40) were
applied and incubated during 2 hours at 40 1C for hybridization.
After building the signal amplification using bDNA, the probes were
labeled. Type 1 probes were labeled with fast red substrate (alkaline
phosphatase) and type 6 probes were labeled with fast blue substrate
(alkaline phosphatase), respectively. The samples were visualized
under a fluorescence microscope (Leica DMRA, Wetzlar, Germany);
type 1 probes were visualized in red, and type 6 probes were
visualized in green. 4’,6-Diamidino-2-phenylindole was used as a
counterstain.
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